Recombinant multi-species SRp20/SRSF3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SRp20/SRSF3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two transcript variants, one protein-coding and the other non-coding, have been found for this gene. [provided by RefSeq, Sep 2010]
The Alternative Names of target: Pre-mRNA-splicing factor SRP20,SFRS3,SRP20,SRSF3,SRp20,Serine/arginine-rich splicing factor 3,Sfrs3,Splicing factor,Srsf3,X16,arginine/serine-rich 3

Target products collectionGo to SRp20/SRSF3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1820-Ag-1/ GM-Tg-hg-IP1820-Ag-2 Human SRp20/SRSF3 protein Human
GM-Tg-rg-IP1820-Ag-1/ GM-Tg-rg-IP1820-Ag-2 Rat SRp20/SRSF3 protein Rat
GM-Tg-mg-IP1820-Ag-1/ GM-Tg-mg-IP1820-Ag-2 Mouse SRp20/SRSF3 protein Mouse
GM-Tg-cynog-IP1820-Ag-1/ GM-Tg-cynog-IP1820-Ag-2 Cynomolgus/Rhesus macaque SRp20/SRSF3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1820-Ag-1/ GM-Tg-felg-IP1820-Ag-2 Feline SRp20/SRSF3 protein Feline
GM-Tg-cang-IP1820-Ag-1/ GM-Tg-cang-IP1820-Ag-2 Canine SRp20/SRSF3 protein Canine
GM-Tg-bovg-IP1820-Ag-1/ GM-Tg-bovg-IP1820-Ag-2 Bovine SRp20/SRSF3 protein Bovine
GM-Tg-equg-IP1820-Ag-1/ GM-Tg-equg-IP1820-Ag-2 Equine SRp20/SRSF3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1820-Ag-1/ GM-Tg-hg-IP1820-Ag-2; GM-Tg-rg-IP1820-Ag-1/ GM-Tg-rg-IP1820-Ag-2;
GM-Tg-mg-IP1820-Ag-1/ GM-Tg-mg-IP1820-Ag-2; GM-Tg-cynog-IP1820-Ag-1/ GM-Tg-cynog-IP1820-Ag-2;
GM-Tg-felg-IP1820-Ag-1/ GM-Tg-felg-IP1820-Ag-2; GM-Tg-cang-IP1820-Ag-1/ GM-Tg-cang-IP1820-Ag-2;
GM-Tg-bovg-IP1820-Ag-1/ GM-Tg-bovg-IP1820-Ag-2; GM-Tg-equg-IP1820-Ag-1/ GM-Tg-equg-IP1820-Ag-2
Products Name SRp20/SRSF3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SRp20/SRSF3
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SRp20/SRSF3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.